Mathers Edward T. - 11 Jun 2025 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role: Director
Signature: /s/ Zachary Bambach, attorney-in-fact
Issuer symbol: TRVI
Transactions as of: 11 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 13 Jun 2025, 16:09:28 UTC
Previous filing: 06 Jun 2025
Next filing: 23 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mathers Edward T	Director	104 5TH AVE, 19TH FLOOR, NEW YORK	/s/ Zachary Bambach, attorney-in-fact	13 Jun 2025	0001328625

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRVI	Nonstatutory Stock Option (right to buy)	Award	$0	+45,000		$0.000000	45,000	11 Jun 2025	Common Stock	45,000	$6.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 11, 2025. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.